Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 12, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Initiates Its Outpatient Heart Failure Strategy Using Aquadex Ultrafiltration Therapy

MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced key...
June 29, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF

MINNEAPOLIS, June 29, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the first patient has been enrolled in the company’s pivotal REVERSE-HF (Ultrafiltration Versus IV...
June 14, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Expands Pediatric Access to Ultrafiltration Therapy at Hospitals in Florida and Arkansas

MINNEAPOLIS, June 14, 2022 (GLOBE NEWSWIRE) -- Improving access to life-saving fluid management therapies is a commitment by which Nuwellis, Inc. (Nasdaq: NUWE) stands. The company today announced...
May 17, 2022 16:25 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum

MINNEAPOLIS, May 17, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that the Company’s 2022 Annual Meeting of Stockholders, on May 17, 2022 at 2:00 p.m., was convened and...
May 10, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Announces First Quarter 2022 Financial Results

MINNEAPOLIS, May 10, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the first quarter ended March 31, 2022, which included the following highlights: ...
May 09, 2022 13:11 ET | Source: Nuwellis, Inc.

Nuwellis Announces Presentation of Aquadex®-Related Abstracts at the 2022 Pediatric Academic Societies Meeting

MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the presentation of three Aquadex-related abstracts at the annual Pediatric Academic Societies (PAS)...
April 12, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. To Announce First Quarter 2022 Financial Results on May 10, 2022

MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its first quarter 2022 financial results will be released on Tuesday, May 10, 2022. The company...
March 15, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study

MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the...
March 01, 2022 08:00 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results

MINNEAPOLIS, March 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the fourth quarter and full year ended December 31, 2021, which included the following...
February 22, 2022 17:15 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MINNEAPOLIS, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective February 22, 2022, the independent directors approved equity awards under Nuwellis’ 2021...